Drugs / Ad-HGF
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02844283 | Nov 2016 → Jul 2018 | myocardial infarction | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
| Phase 1/2 | NCT01925352 | Nov 2012 → Dec 2015 | myocardial ischemia | The First Affiliated Hospital with Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad-HGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01925352 ↗ |
| Route | Other | “via intracoronary injection into infarct-related artery” NCT02844283 ↗ |